Callan Family Office’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$955K Buy
42,231
+20,544
+95% +$461K 0.02% 607
2026
Q1
$489K Sell
21,687
-7,490
-26% -$172K 0.01% 775
2025
Q4
$695K Buy
29,177
+1,563
+6% +$38.9K 0.01% 662
2025
Q3
$727K Sell
27,614
-2,263
-8% -$58.2K 0.02% 440
2025
Q2
$854K Buy
29,877
+9,979
+50% +$268K 0.03% 436
2025
Q1
$495K Sell
19,898
-2,285
-10% -$54.4K 0.04% 321
2024
Q4
$502K Buy
+22,183
New +$482K 0.03% 367

Other funds holding FMS

Callan Family Office's FMS Position: Q2 2026 in Review

Callan Family Office increased its Fresenius Medical Care (FMS) stake by 95% in Q2 2026, buying an estimated $461K and bringing the position to 42,231 shares worth $955K. The position accounts for 0.02% of the portfolio, ranked #607.

Callan Family Office first reported a position in FMS in Q4 2024 and has held it in 7 quarters since. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Callan Family Office held 42,231 shares of Fresenius Medical Care worth $955K as of Q2 2026.
  • Callan Family Office bought 20,544 Fresenius Medical Care shares in Q2 2026, an estimated $461K.
  • Fresenius Medical Care made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #607 holding.
  • Callan Family Office first reported a position in Fresenius Medical Care in Q4 2024 and has held it in 7 quarters since.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.